Ataluren

CHEMBL256997 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

284.2 g/mol

LogP

3.1

Phase

4

A small molecule that allows the ribosome to read through premature stop codons in messenger RNA caused by nonsense mutations, enabling production of a functional protein in conditions such as Duchenne muscular dystrophy.

Moleküler Ağırlık

284,2400 g/mol

LogP

3,10

TPSA

76,20 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Epilepsy Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1

InChI

InChI=1S/C15H9FN2O3/c16-12-7-2-1-6-11(12)14-17-13(18-21-14)9-4-3-5-10(8-9)15(19)20/h1-8H,(H,19,20)

Molecular Formula

C15H9FN2O3

HBD / HBA

1 / 6

Döndürülebilir Bağlar

3

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A small molecule that allows the ribosome to read through premature stop codons in messenger RNA caused by nonsense mutations, enabling production of a functional protein in conditions such as Duchenne muscular dystrophy.

Yes, Ataluren is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL256997. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11219835. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Ataluren PillFYI'da

Yapı

Hızlı Veriler

Formül: C15H9FN2O3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.